Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.0030
-0.0010 (-25.00%)
Aug 7, 2025, 10:45 AM AEST
Sage Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 12.43 million as of August 6, 2025. Its market cap has decreased by -19.94% in one year.
Market Cap
12.43M
Enterprise Value
7.36M
Revenue
2.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 12.43M, a decrease of -87.25%. That is a compound annual growth rate of -36.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 9.32M | -15.43% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | 97.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.54B |
| Pro Medicus | 33.39B |
| Cochlear | 20.52B |
| Sonic Healthcare | 13.80B |
| Ramsay Health Care | 8.81B |
| Telix Pharmaceuticals | 6.29B |
| Ansell | 4.47B |
| Mesoblast | 3.11B |